PS
WST icon

Principal Securities’s West Pharmaceutical WST Stock Holding History

Principal Securities’s Portfolio WST Stock Details WST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$237K Buy
+660
New +$202K ﹤0.01% 1444
2026
Q1 		– Sell
-951
Closed -$262K – 1479
2025
Q4 		$262K Sell
951
-51
-5% -$13.9K ﹤0.01% 1198
2025
Q3 		$263K Sell
1,002
-94
-9% -$22.8K ﹤0.01% 1167
2025
Q2 		$240K Buy
1,096
+107
+11% +$22.9K ﹤0.01% 1154
2025
Q1 		$324K Hold
989
– – 0.01% 938
2024
Q4 		$324K Sell
989
-21
-2% -$6.61K 0.01% 933
2024
Q3 		$303K Buy
1,010
+19
+2% +$5.82K 0.01% 928
2024
Q2 		$326K Buy
991
+266
+37% +$94K 0.01% 852
2024
Q1 		$287K Buy
725
+23
+3% +$8.51K 0.01% 876
2023
Q4 		$247K Buy
+702
New +$248K 0.01% 863

Other funds holding WST

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
GIM
Generation Investment Management London, United Kingdom $10.3B AUM 4.84% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

Principal Securities's WST Position: Q2 2026 in Review

Principal Securities opened a new position in West Pharmaceutical (WST) in Q2 2026: 660 shares worth $237K. The stake represents ﹤0.01% of the portfolio and ranks #1444 among its holdings. This is a return to the name: Principal Securities previously reported a position in WST as recently as Q4 2025.

Principal Securities first reported a position in WST in Q4 2023 and has held it in 10 quarters since. The position peaked at $326K in Q2 2024. 831 funds tracked by Wall St. Rank hold WST as of Q2 2026.

  • Principal Securities held 660 shares of West Pharmaceutical worth $237K as of Q2 2026.
  • West Pharmaceutical was a new Principal Securities position in Q2 2026.
  • West Pharmaceutical made up ﹤0.01% of Principal Securities's portfolio in Q2 2026, its #1444 holding.
  • Principal Securities first reported a position in West Pharmaceutical in Q4 2023 and has held it in 10 quarters since.
  • Principal Securities's West Pharmaceutical position peaked at $326K in Q2 2024.
  • 831 funds tracked by Wall St. Rank held West Pharmaceutical as of Q2 2026.

Based on Principal Securities's 13F filing for Q2 2026, filed 4 Aug 2026.